AzTrials
AzTrials

StrokeNCT04312126

The Beneficial Effects of Naps on Motor Learning

An observational study of Stroke, run by National Institute of Neurological Disorders and Stroke (NINDS) at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Background: Memory consolidation is the process by which memories become stable, long-term representations in the brain. Consolidation of a motor skill is dependent upon sleep. Some research shows that daytime naps improve people s motor performance and memory retention. Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Stroke
What is being tested?
MRI system and MEG system
Type of treatment
Medical device
How many people
199 participants
Where
1 siteUnited States
Study dates
4 Mar 2021to 30 Mar 2030
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Right-handed adults between the ages of 18 and 80.

Who may be able to join

  • Age 18-35 (Arm 1) or 50-80 (Arms 2).
  • English speaking.
  • Clear right-hand dominance (>74 on Edinburgh Handedness Inventory).
  • Normal neurological examination as determined by the screening clinician.
  • Age 18 or older
  • Willing and able to provide consent
Show all 9Show fewer
  • Experienced a stroke 6 months ago or more that affected at least one of the upper extremities at time of stroke diagnosis
  • Ability to perform the study task as assessed during physical examination
  • English-speaking

Who cannot join

  • HCPS affiliated NIH staff (i.e. - staff from our section).
  • Current pregnancy.
  • Contraindications for MRI or MEG.
  • Use of sleep medications within 24 hours of Experimental Session participation.
  • Severe or progressive neurological, psychological or medical condition as determined by the screening clinician.
  • STROKE PATIENTS:
Show all 12Show fewer
  • HCPS-affiliated NIH staff (i.e. - staff from our section).
  • Current pregnancy
  • History of large stroke lesions in brainstem or cerebellum as determined by screening clinician
  • Severe or progressive neurological disorder other than stroke (e.g., Parkinson s disease or multiple sclerosis) as determined by the screening clinician
  • Uncontrolled heart, lung, kidney, gastrointestinal, metabolic, psychiatric, sleep, or endocrine disorders as determined by the screening clinician
  • Contraindications for MRI or MEG.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Catherine L Blumhorst, C.R.N.P. contact

(301) 451-1335

cathy.blumhorst@nih.gov

Leonardo G Cohen, M.D. contact

(301) 496-9782

cohenl1@mail.nih.gov

United States1 site, 1 recruiting
  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892

    For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR), 800-411-1222 ext. TTY8664111010, prpl@cc.nih.gov

    Recruiting

Other trials in United States

About this study

Official title: Mechanisms Underlying the Beneficial Effects of Naps on Motor Learning

Background:

Memory consolidation is the process by which memories become stable, long-term representations in the brain. Consolidation of a motor skill is dependent upon sleep. Some research shows that daytime naps improve people s motor performance and memory retention. Researchers want to find out how daytime naps may contribute to learning and support consolidation of motor skill memories.

Read more

Objective:

To learn the role of memory replay during wakeful rest and sleep (naps) in retaining a newly learned skill.

Eligibility:

English-speaking adults ages 18 and older with chronic stroke, or healthy, right-handed, English-speaking adults ages 18-35 and 50-80

Design:

Participants will be screened with:

  • medical history
  • neurological history
  • medicine review
  • medical exam
  • neurological exam.

Participants will have a magnetic resonance imaging (MRI) scan of the brain. For this, they will lie down in a scanner. The scanner makes loud noises, so they will wear earplugs. They will fill out an MRI screening form before each MRI.

Participants will also have magnetoencephalography (MEG). MEG maps brain activity. It does this by recording the magnetic fields produced by naturally occurring electrical currents in the brain. For MEG, participants will lie down in the MEG room. Their eye movements may be recorded by a video camera.

Participants will have behavior testing. They will practice typing random keys. Then they will repeatedly type a custom sequence that they see on a computer screen. Then they will take a 2-hour nap. Then they will type the same sequence again.

Participants will have no more than 4 visits at the NIH over 3 months. Visits will last 2-4 hours each.

Read the detailed description

Study Description:

We will investigate the within-individual contribution of wakeful and sleep neural replay to motor skill consolidation in three groups: (a) young healthy subjects, (b) older healthy subjects and (c) patients with chronic stroke.

Objectives:

The primary aim is to determine the relative contribution of neural replay during wakeful rest and sleep to consolidation of a newly learned skill in young and older healthy volunteers, and in chronic stroke patients with magnetoencephalography (MEG). The secondary aim is to evaluate differences in replay rates between these subject cohorts. We will also explore differences in replay rates, spatiotemporal dynamics of neural replay and sleep spindles to generate additional hypotheses and preliminary data for future studies.

Endpoints:

The primary endpoint measure is motor skill consolidation (i.e., offline change in correct sequence typing speed following a nap). The secondary endpoint measure is neural replay rate. Exploratory endpoints measures are spatial (i.e. - parcellated source space) and time-frequency maps of neural replay during wakeful rest and sleep, and changes in button-press finger movement kinematics during learning.

Conditions
Stroke
Being tested
MRI system, MEG system
Keywords
Motor Skill, Sleep, Neural Replay, Natural History
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MRI systemDevice

    MRI system - GE Discovery MR750 3T

  • MEG systemDevice

    MEG system The CTF MEG 275 Magnetoencephalography (MEG) scanner system

Study groups in NCT04312126
Study groupRoleWhat they receive
Arm 146 healthy young (18-35) volunteers
Arm 246 healthy older (50-80) volunteers
Arm 346 chronic (>6 months post-stroke) stroke patients
Receives: Device: MRI system; Device: MEG system

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The primary endpoint measure is the degree to which motor skill consolidation (i.e., offline change in correct sequence typing speed) is predicted by replay rates during wakeful rest and sleep, and spindle rates during sleep (i.e. multiple r...

    The primary endpoint measure is the degree to which motor skill consolidation (i.e., offline change in correct sequence typing speed) is predicted by replay rates during wakeful rest and sleep, and spindle rates during sleep (i.e. multiple regression model with 3 predictors).

    Measured: 4 years

Secondary outcomes (1)
  1. Exploratory endpoints measures are spatial (i.e. - parcellated source space) and time-frequency maps of neural replay during wakeful rest and sleep.

    Exploratory endpoints measures are spatial (i.e. - parcellated source space) and time-frequency maps of neural replay during wakeful rest and sleep.

    Measured: 4 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2020
  2. Study start4 Mar 2021
  3. Primary completion30 Mar 2030 (estimated)
  4. Study completion30 Mar 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
199 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04312126
Sponsor's protocol ID
200060
Other IDs
20-N-0060
Status last verified
18 Sep 2026
First submitted
14 Mar 2020
Last updated
22 Sep 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke, run by National Institute of Neurological Disorders and Stroke (NINDS) at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Catherine L Blumhorst, C.R.N.P. ((301) 451-1335, cathy.blumhorst@nih.gov), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The primary endpoint measure is the degree to which motor skill consolidation (i.e., offline change in correct sequence typing speed) is predicted by replay rates during wakeful rest and sleep, and spindle rates during sleep (i.e. multiple r... (time frame: 4 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in